News | March 04, 2013

Hologic and Armor Mobile Systems partner to take 3-D mammography, a revolutionary new imaging technology, on a yearlong, U.S. coast-to-coast tour

Hologic 3-D Mammography Coach Armor Mobile Systems

March 4, 2013 — Hologic Inc. announced it has partnered with Armor Mobile Systems to take Hologic's 3-D mammography (breast tomosynthesis), on a yearlong U.S. tour in a new mobile mammography coach.

Calling the tour, "A More Accurate Mammogram: The 3D Tour," the mobile coach will cross the country over the next 12 months spreading the word about the benefits of 3-D mammography. Unlike conventional 2-D mammography, where the presence of overlapping breast tissue can make it more difficult to detect cancer, Hologic's 3-D mammography procedure is designed to allow doctors to see the breast more clearly, particularly for women with dense breasts. Clinical evidence shows that a combination of conventional 2-D with 3-D mammography in the same breast cancer screening exam significantly increases invasive cancer detection while greatly reducing unnecessary call backs.

"We are thrilled to take our 3-D mammography system on the road," said Rob Cascella, Hologic's president and chief executive officer. "Hologic's 3-D technology is designed to provide a more detailed, accurate picture of the breast than conventional mammography. 2-D plus 3-D combined in the same exam has been shown to improve early detection while reducing false positives and unnecessary call backs by as much as 40 percent. We know the chance for successful treatment is greatest when cancer is detected early, and we are committed to making our 3-D mammography available to women everywhere."

"As an industry leader in custom specialty vehicles, we designed and built this mobile mammography coach to show America what the future of mammography looks like and the importance of accessibility," said Dave Moushey, president of Armor Mobile Systems. "We are proud to partner with Hologic on this important initiative to generate attention for the importance of 3-D mammography across the country."

As the 3-D mammography coach travels the country, experts will be on-hand to answer questions about this breakthrough breast cancer screening technology, as well as the benefits of mobile mammography. At most stops, the general public will have an opportunity to tour the coach and learn firsthand about how Hologic's 3-D mammography is significantly increasing cancer detection.

For more information: www.Hologic3D.com


Related Content

News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
Subscribe Now